Electromedical Technologies, Inc.
EMED · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $1 | $3 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $2 | $2 | $2 | $2 |
| Enterprise Value | $2 | $2 | $3 | $5 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | -56.4% | 17.3% | 26.7% | – |
| Gross Profit | $0 | $1 | $1 | $1 |
| % Margin | 64.8% | 77.5% | 77.3% | 78% |
| EBITDA | -$1 | -$2 | -$3 | -$5 |
| % Margin | -172.2% | -127.7% | -230.9% | -567% |
| Net Income | -$1 | -$3 | -$3 | -$8 |
| % Margin | -219.6% | -195.8% | -301.6% | -934.6% |
| EPS Diluted | -0.002 | -0.007 | -0.027 | -0.24 |
| % Growth | 71.4% | 73.9% | 88.8% | – |
| Operating Cash Flow | -$0 | -$1 | -$1 | -$1 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$2 | -$1 | -$1 |